Shionogi Inc. v. Hi-Tech Pharmacal Co., Inc.
1:16-cv-00676
Overview
Parties
Defendant
Hi-Tech Pharmacal Co., Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Concordia Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Shionogi Inc. v. Actavis Laboratories UT, Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6793931
Ectoparasite asphyxiator compositions and methods for their applications
|
Filed: 2002-07-11
Issued: 2004-09-21
|
Expired (Term Ended)
Expires: 2022-07-11
|
|
|
US7294342
Ectoparasite asphyxiator compositions and methods for their application
|
Filed: 2003-01-04
Issued: 2007-11-13
|
Expired (Term Ended)
+501d PTA
Expires: 2024-05-19
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
0
Granted
0
Denied
0
Pending / Review
5
Motions by Category
Key Dispositive Motions & Rulings